scholarly article | Q13442814 |
P50 | author | Mark R. Boothby | Q91454598 |
Do-Sim Park | Q39964421 | ||
Jin Chen | Q55189464 | ||
P2093 | author name string | Jin Chen | |
Yoonha Hwang | |||
Ki Taek Nam | |||
Sung Hoon Cho | |||
Ross Potter | |||
Keunwook Lee | |||
Emmanuel Volanakis | |||
Prathyusha Gudapati | |||
P2860 | cites work | The effect of rapamycin on T cell development in mice | Q72285894 |
NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development | Q73291757 | ||
Transgenic mice with hematopoietic and lymphoid specific expression of Cre | Q78842092 | ||
NF-kappaB couples protein kinase B/Akt signaling to distinct survival pathways and the regulation of lymphocyte homeostasis in vivo | Q81180198 | ||
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex | Q24295120 | ||
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton | Q24299873 | ||
Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia. | Q24305527 | ||
Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling | Q24323370 | ||
mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1) | Q24324148 | ||
The PI3K-PDK1 connection: more than just a road to PKB | Q24531972 | ||
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer | Q27646556 | ||
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells | Q28141009 | ||
NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase | Q28144326 | ||
NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling | Q28144330 | ||
PTEN: one gene, many syndromes | Q28203387 | ||
PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation | Q28242875 | ||
SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity | Q28262782 | ||
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1 | Q28276788 | ||
BCR/ABL-mediated downregulation of genes implicated in cell adhesion and motility leads to impaired migration toward CCR7 ligands CCL19 and CCL21 in primary BCR/ABL-positive cells | Q28304582 | ||
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB | Q28306356 | ||
Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability | Q28504594 | ||
Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor | Q28573596 | ||
The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C | Q28587901 | ||
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia | Q29614269 | ||
mTOR signaling at a glance | Q29619857 | ||
Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. | Q30440717 | ||
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor | Q33597663 | ||
Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss. | Q33677433 | ||
Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1. | Q33965862 | ||
Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells | Q33979948 | ||
Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells | Q34004994 | ||
The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia. | Q34235332 | ||
PDK2: a complex tail in one Akt. | Q34467820 | ||
Requirement for ribosomal protein S6 kinase 1 to mediate glycolysis and apoptosis resistance induced by Pten deficiency | Q34572866 | ||
The two TORCs and Akt. | Q34617423 | ||
The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. | Q34801853 | ||
IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation. | Q34836259 | ||
Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy | Q34891582 | ||
Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitors | Q35091507 | ||
Activating Notch1 mutations in mouse models of T-ALL. | Q35849320 | ||
Notch1-dependent lymphomagenesis is assisted by but does not essentially require pre-TCR signaling | Q35849825 | ||
Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation. | Q35901256 | ||
Regulation of lymphoid development, differentiation, and function by the Notch pathway. | Q36072476 | ||
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis | Q36384467 | ||
Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions | Q36399587 | ||
Key factors in the organized chaos of early T cell development | Q36715280 | ||
CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia | Q37113435 | ||
PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells. | Q37129661 | ||
Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia | Q37215995 | ||
High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia | Q37268926 | ||
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers | Q37272977 | ||
Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia | Q37420510 | ||
NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia. | Q37439353 | ||
Notch signalling in solid tumours: a little bit of everything but not all the time | Q37867484 | ||
Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. | Q39457088 | ||
Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia. | Q39650704 | ||
In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation | Q39831998 | ||
Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia | Q40158237 | ||
Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. | Q40195204 | ||
Direct role of NF-kappaB activation in Toll-like receptor-triggered HLA-DRA expression | Q40291332 | ||
Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism | Q40390896 | ||
Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase | Q40533718 | ||
Persistent activation of NF-kappa B by the tax transforming protein involves chronic phosphorylation of IkappaB kinase subunits IKKbeta and IKKgamma | Q41476010 | ||
Notch-induced T cell development requires phosphoinositide-dependent kinase 1. | Q41953543 | ||
Phosphoinositide (3,4,5)-triphosphate binding to phosphoinositide-dependent kinase 1 regulates a protein kinase B/Akt signaling threshold that dictates T-cell migration, not proliferation | Q41981684 | ||
Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways | Q42099912 | ||
The serine kinase phosphoinositide-dependent kinase 1 (PDK1) regulates T cell development | Q44839270 | ||
Protein kinase C betaII regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion. | Q45057108 | ||
Deficient T cell fate specification in mice with an induced inactivation of Notch1. | Q45345200 | ||
The pharmacology of mTOR inhibition | Q46041824 | ||
Regulation of alphabeta/gammadelta T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling | Q47607371 | ||
Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. | Q51908453 | ||
Unequal Contribution of Akt Isoforms in the Double-Negative to Double-Positive Thymocyte Transition | Q62663058 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | leukemia | Q29496 |
thymocyte | Q7799635 | ||
P304 | page(s) | 713-728 | |
P577 | publication date | 2012-04-02 | |
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia | |
P478 | volume | 209 |
Q36141169 | A critical role for Rictor in T lymphopoiesis |
Q36199919 | Control of peripheral tolerance by regulatory T cell-intrinsic Notch signaling. |
Q36758895 | Correlation of Notch1, pAKT and nuclear NF-κB expression in triple negative breast cancer |
Q37265027 | Cross talk between the Akt and p38α pathways in macrophages downstream of Toll-like receptor signaling |
Q42950231 | Cutting edge: Discrete functions of mTOR signaling in invariant NKT cell development and NKT17 fate decision. |
Q34974398 | Emerging function of mTORC2 as a core regulator in glioblastoma: metabolic reprogramming and drug resistance. |
Q38367426 | Evolving perspectives of mTOR complexes in immunity and transplantation |
Q51051812 | Hyperactivation of mTORC1 and mTORC2 by multiple oncogenic events causes addiction to eIF4E-dependent mRNA translation in T-cell leukemia |
Q50067591 | Investigating Cellular Quiescence of T Lymphocytes and Antigen-Induced Exit from Quiescence. |
Q37640929 | Loss of mTOR complex 1 induces developmental blockage in early T-lymphopoiesis and eradicates T-cell acute lymphoblastic leukemia cells |
Q33645556 | Maintaining glycogen synthase kinase-3 activity is critical for mTOR kinase inhibitors to inhibit cancer cell growth |
Q36216334 | Mammalian target of rapamycin complex 1 (mTORC1) and 2 (mTORC2) control the dendritic arbor morphology of hippocampal neurons |
Q41873879 | Mammalian target of rapamycin complex 2 modulates αβTCR processing and surface expression during thymocyte development |
Q35043677 | Mammalian target of rapamycin complex 2 regulates invariant NKT cell development and function independent of promyelocytic leukemia zinc-finger |
Q93072823 | Metabolic regulation of T cell development by Sin1-mTORC2 is mediated by pyruvate kinase M2 |
Q59418269 | Metabolic signaling directs the reciprocal lineage decisions of αβ and γδ T cells |
Q36602853 | MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies |
Q38810904 | Microenvironmental cues for T-cell acute lymphoblastic leukemia development |
Q89771859 | Molecular Mechanisms of Notch Signaling in Lymphoid Cell Lineages Development: NF-κB and Beyond |
Q42583738 | Mouse gene targeting reveals an essential role of mTOR in hematopoietic stem cell engraftment and hematopoiesis |
Q35000084 | Mtor-Fanconi Anemia DNA Damage Repair Pathway in Cancer. |
Q42555479 | NGF signaling in PC12 cells: the cooperation of p75(NTR) with TrkA is needed for the activation of both mTORC2 and the PI3K signalling cascade |
Q37011956 | Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways |
Q36610031 | Non-canonical antagonism of PI3K by the kinase Itpkb delays thymocyte β-selection and renders it Notch-dependent |
Q54495106 | Notch and the survival of regulatory T cells: location is everything! |
Q39100271 | Notch regulates Th17 differentiation and controls trafficking of IL-17 and metabolic regulators within Th17 cells in a context-dependent manner |
Q26765033 | Notch signaling: its roles and therapeutic potential in hematological malignancies |
Q40973885 | PDK1 plays a vital role on hematopoietic stem cell function. |
Q37343899 | Phosphorylation of the TOR ATP binding domain by AGC kinase constitutes a novel mode of TOR inhibition. |
Q38223047 | Pleiotropic roles of mTOR complexes in haemato-lymphopoiesis and leukemogenesis |
Q37021907 | Rapamycin-resistant and torin-sensitive mTOR signaling promotes the survival and proliferation of leukemic cells |
Q54108534 | Regulation of Hematopoietic Cell Development and Function Through Phosphoinositides. |
Q38293289 | Regulation of T cells by mTOR: the known knowns and the known unknowns |
Q37215135 | Requirement for Rictor in homeostasis and function of mature B lymphoid cells. |
Q35662372 | Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation |
Q38753222 | Rictor has a pivotal role in maintaining quiescence as well as stemness of leukemia stem cells in MLL-driven leukemia |
Q35217127 | Rictor is required for early B cell development in bone marrow |
Q37424679 | Roles of PINK1, mTORC2, and mitochondria in preserving brain tumor-forming stem cells in a noncanonical Notch signaling pathway |
Q38914374 | Roles of mTOR complexes in the kidney: implications for renal disease and transplantation. |
Q98776112 | Searching for the real function of mTOR signaling in the regulation of PD-L1 expression |
Q26767443 | Signaling in T cells - is anything the m(a)TOR with the picture(s)? |
Q93367277 | Sin1-mTORC2 signaling drives glycolysis of developing thymocytes |
Q37684998 | Substrate specificity of TOR complex 2 is determined by a ubiquitin-fold domain of the Sin1 subunit. |
Q58696922 | The role of mTOR-mediated signals during haemopoiesis and lineage commitment |
Q56378380 | Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update |
Q42833446 | Transmembrane Inhibitor of RICTOR/mTORC2 in Hematopoietic Progenitors |
Q42156145 | Tuning mTOR activity for immune balance. |
Q34986648 | mTOR Links Environmental Signals to T Cell Fate Decisions. |
Q37373850 | mTOR and metabolic pathways in T cell quiescence and functional activation |
Q35430711 | mTOR and metabolic regulation of conventional and regulatory T cells. |
Q39210322 | mTOR complex 2 is involved in regulation of Cbl-dependent c-FLIP degradation and sensitivity of TRAIL-induced apoptosis |
Q37330582 | mTOR is critical for intestinal T-cell homeostasis and resistance to Citrobacter rodentium |
Q27027963 | mTOR kinase inhibitors as potential cancer therapeutic drugs |
Q38209860 | mTOR signaling and transcriptional regulation in T lymphocytes |
Q34919712 | mTOR signaling, Tregs and immune modulation |
Q38034265 | mTOR, metabolism, and the regulation of T-cell differentiation and function |
Q38704683 | mTORC signaling in hematopoiesis |
Q38982579 | mTORC1 and mTORC2 in cancer and the tumor microenvironment |
Q90162652 | mTORC1 as a cell-intrinsic rheostat that shapes development, preimmune repertoire, and function of B lymphocytes |
Q35927028 | mTORC1 in Thymic Epithelial Cells Is Critical for Thymopoiesis, T-Cell Generation, and Temporal Control of γδT17 Development and TCRγ/δ Recombination |
Q37018601 | mTORC2 in Thymic Epithelial Cells Controls Thymopoiesis and T Cell Development |
Search more.